{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:30:12Z","timestamp":1776259812358,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007857","name":"Foundation King Gustaf V 80-\u00e5rsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009793","name":"B\u00f6rje Dahlin Foundation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009800","name":"Professor Nanna Svartz Foundation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011898","name":"Marianne and Marcus Wallenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011898","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.semarthrit.2021.07.016","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T10:58:42Z","timestamp":1627297122000},"page":"983-988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathies"],"prefix":"10.1016","volume":"51","author":[{"given":"Val\u00e9rie","family":"Leclair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Moshtaghi-Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malin","family":"Regardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Holmqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.semarthrit.2021.07.016_bib0001","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.016_bib0002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nan.12380","article-title":"Integrated classification of inflammatory myopathies","volume":"43","author":"Allenbach","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.016_bib0003","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/rheumatology\/kew503","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study","volume":"56","author":"Svensson","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.016_bib0004","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","article-title":"Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study","volume":"77","author":"Dobloug","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.016_bib0005","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3899\/jrheum.101083","article-title":"Healthcare costs of inflammatory myopathies","volume":"38","author":"Bernatsky","year":"2011","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.016_bib0006","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/mus.25686","article-title":"Burden of illness and healthcare resource use in United States patients with sporadic inclusion body myositis","volume":"56","author":"Capkun","year":"2017","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.016_bib0007","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/mus.23384","article-title":"Medical costs and health-care resource use in patients with inflammatory myopathies in an insured population","volume":"46","author":"Furst","year":"2012","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.016_bib0008","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1080\/03007995.2018.1486294","article-title":"Health care costs and comorbidities for patients with inclusion body myositis","volume":"34","author":"Keshishian","year":"2018","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.016_bib0009","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/acr.23190","article-title":"Predictors of hospitalization, length of stay, and cost of care among adults with Dermato-myositis in the United States","volume":"69","author":"Kwa","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.07.016_bib0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3111\/13696998.2016.1151433","article-title":"Healthcare resource utilization and work loss in Dermato-myositis and Poly-myositis patients in a privately-insured US population","volume":"19","author":"Bradford Rice","year":"2016","journal-title":"J Med Econ"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.07.016_bib0011","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1177\/0961203318768882","article-title":"Incremental direct medical costs of systemic lupus erythematosus patients in the years preceding diagnosis: a general population-based study","volume":"27","author":"McCormick","year":"2018","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.07.016_bib0012","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10067-016-3446-z","article-title":"Welfare costs in patients with rheumatoid arthritis and their partners compared with matched controls: a register-based study","volume":"36","author":"L\u00f8ppenthin","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.016_bib0013","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/annrheumdis-2013-204080","article-title":"Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?","volume":"74","author":"Eriksson","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.016_bib0014","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/art.24086","article-title":"The cost of systemic sclerosis","volume":"61","author":"Bernatsky","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.07.016_bib0015","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.semarthrit.2015.11.013","article-title":"Direct and indirect costs for systemic lupus erythematosus in Sweden. a nationwide health economic study based on five defined cohorts","volume":"45","author":"J\u00f6nsen","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.07.016_bib0016","unstructured":"Pont\u00e9n J, R\u00f6nnholm G, Ski\u00f6ld P, et\u00a0al. PPRI Pharma Profile Sweden 2017.https:\/\/www.tlv.se\/download\/18.1d85645215ec7de284611ebd\/1510316381520\/ppri_pharma_profile_sweden_2017.pdf (accessed February 2020)"},{"key":"10.1016\/j.semarthrit.2021.07.016_bib0017","unstructured":"Bremell T. L\u00e4karbemanning f\u00f6r Reumatologi mars 2019. https:\/\/svenskreumatologi.se\/wpcontent\/uploads\/2019\/05\/lacc88karbemanning-2019.pdf (accessed February 2020)"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.07.016_bib0018","first-page":"512","article-title":"Use of biologic agents in idiopathic inflammatory myopathies in Sweden: a descriptive study of real life treatment","volume":"35","author":"Svensson","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.016_bib0019","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/rheumatology\/kex413","article-title":"Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis","volume":"57","author":"Pinal-Fernandez","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.016_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-8510(01)00169-5","article-title":"DRG-related prices applied in a public health care system\u2013can Finland learn from Norway and Sweden?","volume":"59","author":"Mikkola","year":"2002","journal-title":"Health Policy"},{"key":"10.1016\/j.semarthrit.2021.07.016_bib0021","unstructured":"Sveriges Kommuner och regioner. KPP somatik. https:\/\/skr.se\/ekonomijuridikstatistik\/statistik\/kostnadperpatientkpp\/kppsomatik.1077.html (accessed February 2020)"},{"key":"10.1016\/j.semarthrit.2021.07.016_bib0022","unstructured":"Socialstyrelsen. Logiken i DRG. 2019. https:\/\/www.socialstyrelsen.se\/utveckla-verksamhet\/e-halsa\/klassificering-och-koder\/drg\/logiken-i-drg\/."},{"key":"10.1016\/j.semarthrit.2021.07.016_bib0023","unstructured":"L\u00e4kemedelsindustrif\u2002reningen. https:\/\/www.fass.se\/LIF\/startpage (accessed February 2020)"},{"key":"10.1016\/j.semarthrit.2021.07.016_bib0024","unstructured":"Statistikmyndigheten. [February 6, 2020]. https:\/\/www.scb.se. (accessed February 2020)"},{"issue":"7243","key":"10.1016\/j.semarthrit.2021.07.016_bib0025","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/bmj.320.7243.1197","article-title":"How should cost data in pragmatic randomised trials be analysed?","volume":"320","author":"Thompson","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2021.07.016_bib0026","series-title":"R: A language and environment for statistical computing","year":"2019"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.07.016_bib0027","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/jgs.17096","article-title":"Examining early and late onset of multi-morbidity in the Canadian Longitudinal Study on Aging","volume":"69","author":"Nicholson","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.semarthrit.2021.07.016_bib0028","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/CLEP.S153458","article-title":"The epidemiology of polypharmacy in older adults: register-based prospective cohort study","volume":"10","author":"Morin","year":"2018","journal-title":"Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.016_bib0029","first-page":"265","article-title":"Work ability in patients with polymyositis and dermato-myositis: an explorative and descriptive study","volume":"53","author":"Regardt","year":"2015","journal-title":"Work"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.016_bib0030","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/eurpub\/cku075","article-title":"The gender gap in sickness absence: long-term trends in eight European countries","volume":"24","author":"Mastekaasa","year":"2014","journal-title":"Eur J Public Health"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.07.016_bib0031","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/eurpub\/ckx054","article-title":"Examination of the double burden hypothesis-a systematic review of work-family conflict and sickness absence","volume":"27","author":"Nilsen","year":"2017","journal-title":"Eur J Public Health"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.07.016_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200788","article-title":"Gender equality in sickness absence tolerance: attitudes and norms of sickness absence are not different for men and women","volume":"13","author":"L\u00f8set","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.016_bib0033","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The Euro-Myositis registry: an international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.07.016_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/acr.23560","article-title":"Venous thromboembolic events in idiopathic inflammatory myopathy - occurrence and relation to disease onset","author":"Antovic","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.07.016_bib0035","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3899\/jrheum.181248","article-title":"Acute coronary syndrome in idiopathic inflammatory Myopathies: a population-based study","volume":"46","author":"Leclair","year":"2019","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.07.016_bib0036","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/acr.23702","article-title":"The risk of ischemic and hemorrhagic stroke in patients with Idiopathic inflammatory Myopathies: a Swedish population-based cohort study","volume":"71","author":"Moshtaghi-Svensson","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221001475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221001475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:06:02Z","timestamp":1758733562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017221001475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0049017221001475"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.07.016","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}